Ardelyx | ARDX - Sales Revenues

Stock Price
6.62
Daily Change
0.06 0.91%
Monthly
-15.13%
Yearly
29.80%
Q1 Forecast
5.55

Ardelyx reported $110.33M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Amgen USD 9.9B 340M Dec/2025
Ardelyx USD 110.33M 12.67M Sep/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Curis USD 2.55M 460K Jun/2024
Sanofi EUR 12.2B 3.19B Dec/2025
TG Therapeutics USD 192.57M 30.87M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
Xoma USD 25K 5M Sep/2024